Standardized Response Mean values from baseline to 3, 6, and 12 months showed that DC was the most sensitive for change, with a respective 0.73, 1.02, and 1.26 in ultrasound scores. Values for tophi were 0.06, 0.57, and 0.91, and 0.20, 0.51 and 0.66 for aggregates.
“Not all patients had reached 12 months of follow-up when we made these calculations,” Dr. Hammer said, noting the limitations of the study. Nevertheless, these interim findings suggest that ultrasound is a valuable tool that can help see how patients fare on a treat-to-target approach, she concluded.
Dr. Hammer had no conflicts of interest to disclose.
SOURCE: Hammer HB et al. Ann Rheum Dis. 2018;77(Suppl 2):154-5. Abstract OP0211.